Drug abuse and psychopathology.
D000328:Adult; D000342:Affective Symptoms / Q000150:complications; D000662:Amphetamines / Q000009:adverse effects / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy; D001463:Barbiturates / Q000009:adverse effects; D001569:Benzodiazepines; D002648:Child; D003863:Depression / Q000150:complications; D006213:Hallucinogens / Q000009:adverse effects; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy; D008297:Male; D001523:Mental Disorders / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D009293:Opioid-Related Disorders / Q000150:complications; D011605:Psychoses, Substance-Induced / Q000209:etiology; D019966:Substance-Related Disorders / Q000150:complications*
D000662:Amphetamines; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D001463:Barbiturates; D006213:Hallucinogens; D001569:Benzodiazepines